PARA vs. PFE
PARA (Paramount Global Class B) and PFE (Pfizer Inc.) are both stocks. PARA operates in Entertainment (Communication Services), while PFE operates in Drug Manufacturers - General (Healthcare). At a 0.30 correlation, their price movements are largely independent.
Performance
PARA vs. PFE - Performance Comparison
Loading charts...
Returns By Period
PARA
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PFE
- 1D
- -1.44%
- 1M
- -4.56%
- YTD
- 2.61%
- 6M
- 2.69%
- 1Y
- 10.06%
- 3Y*
- -8.03%
- 5Y*
- -4.01%
- 10Y*
- 1.82%
PARA vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PARA Paramount Global Class B | 0.00% | 6.45% | -27.96% | -10.43% | -41.80% | -17.17% | -7.58% | -2.34% | -24.86% | -6.17% |
PFE Pfizer Inc. | 2.61% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
Correlation
The correlation between PARA and PFE is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 2006 | 0.30 |
Over the past year, the correlation between PARA and PFE has dropped to 0.09 - well below their long-term average of 0.30, suggesting their price drivers have been diverging.
Fundamentals
PARA:
$12.23B
PFE:
$141.67B
PARA:
-$0.65
PFE:
$1.31
PARA:
0.37
PFE:
2.23
PARA:
1.05
PFE:
1.57
PARA:
$28.89B
PFE:
$63.32B
PARA:
$8.54B
PFE:
$43.91B
PARA:
$2.64B
PFE:
$16.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PARA vs. PFE — Risk / Return Rank
PARA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
PFE
PARA vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Paramount Global Class B (PARA) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PARA | PFE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.10 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 0.84 | — |
| Martin ratioReturn relative to average drawdown | — | 1.72 | — |
Loading charts...
Drawdowns
PARA vs. PFE - Drawdown Comparison
Loading charts...
Drawdown Indicators
| PARA | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -69.24% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -11.99% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -37.69% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -58.96% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -58.96% | — |
Current DrawdownCurrent decline from peak | — | -48.77% | — |
Average DrawdownAverage peak-to-trough decline | — | -22.91% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 5.85% | — |
Volatility
PARA vs. PFE - Volatility Comparison
Loading charts...
Volatility by Period
| PARA | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 5.49% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 14.28% | — |
Volatility (1Y)Calculated over the trailing 1-year period | — | 23.93% | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | — | 25.50% | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | — | 23.91% | — |
Dividends
PARA vs. PFE - Dividend Comparison
PARA has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.96%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PARA Paramount Global Class B | 0.00% | 0.91% | 1.91% | 2.64% | 5.69% | 3.18% | 2.58% | 1.86% | 1.65% | 1.22% | 1.04% | 1.27% |
PFE Pfizer Inc. | 6.96% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Financials
PARA vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Paramount Global Class B and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PARA vs. PFE - Profitability Comparison
PARA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Paramount Global Class B reported a gross profit of 1.98B and revenue of 8.15B. Therefore, the gross margin over that period was 24.3%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.
PARA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Paramount Global Class B reported an operating income of 207.00M and revenue of 8.15B, resulting in an operating margin of 2.5%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.
PARA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Paramount Global Class B reported a net income of -573.00M and revenue of 8.15B, resulting in a net margin of -7.0%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.
Frequently Asked Questions
PARA and PFE have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for PARA and PFE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer